HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Significance of galectin-3 and CD44v6 expression in differential diagnosis of thyroid nodules].

AbstractOBJECTIVE:
To investigate the difference of galectin-3 and CD44v6 expression between benign and malignant thyroid nodules, and to evaluate their clinical value in distinguishing thyroid cancer from benign thyroid nodules.
METHODS:
The expression of galectin-3 and CD44v6 was immunohistochemically detected by the ABC method in 143 benign and malignant thyroid nodule samples.
RESULTS:
Expression of these two markers in benign thyroid nodules: galectin-3 was negative in 10 cases of para-cancer normal tissue and 14 cases of benign nodules found in the other benign thyroid disease. It was weakly positive in 4 of 52 nodular goiter (7.7%). Also it was weakly positive in 2 of 22 follicular adenomas (9.1%). But all three eosinophilic follicular adenomas were diffusely or focally positive for galectin-3. CD44v6 was negative in 10 cases of para-cancer normal tissue, but positive in 4 of 14 nodular lesions found in benign thyroid diseases (28.6%). It was also positive in 16 of 52 nodular goiters (30.8%), and weakly positive in 7 of 22 follicular adenomas (31.8%). The two markers in malignant lesions: galectin-3 was positive in 50 of 52 thyroid adenocarcinoma (96.2%), CD44v6 was positive in 42 of 52 thyroid adenocarcinoma (80.8%). The positive rate of galectin-3 and CD44v6 expression in thyroid cancer was significantly higher than that in benign thyroid nodule and normal tissue (P < 0.001). The sensitivity, specificity and accuracy of galectin-3 combined with CD44v6 in differentiating benign from malignant thyroid nodule were 80.8%, 93.4%, 88.8%; they were 96.2%, 90.1%, 92.3% for Galectin-3 alone.
CONCLUSION:
The immunohistochemical expression of galectin-3 and CD44v6 by the ABC method is significantly higher in thyroid cancers than in benign thyroid nodules, especially galectin-3 in thyrocyte being helpful in differentiating benign thyroid nodule from thyroid cancer.
AuthorsLi-hua Wang, Yong-ju Zhao, Xiao-ying Wang, Ping Yuan, Wei-qing Xu, Jia-cheng Xiao, Jin-ping Xu, Bang-rao Luo
JournalZhonghua zhong liu za zhi [Chinese journal of oncology] (Zhonghua Zhong Liu Za Zhi) Vol. 27 Issue 9 Pg. 547-50 (Sep 2005) ISSN: 0253-3766 [Print] China
PMID16438854 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • CD44v6 antigen
  • Galectin 3
  • Glycoproteins
  • Hyaluronan Receptors
Topics
  • Adenocarcinoma, Papillary (diagnosis, metabolism)
  • Adenoma (diagnosis, metabolism)
  • Biomarkers, Tumor (biosynthesis)
  • Diagnosis, Differential
  • Female
  • Galectin 3 (biosynthesis)
  • Glycoproteins (biosynthesis)
  • Humans
  • Hyaluronan Receptors (biosynthesis)
  • Immunohistochemistry
  • Male
  • Thyroid Neoplasms (diagnosis, metabolism)
  • Thyroid Nodule (diagnosis, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: